Cambridge-based agriculture company Inari has secured $89 million in Series C funding, according to company database Crunchbase, topping the city’s recent funding headlines. The cash infusion was announced Aug. 1 and led by Flagship Pioneering.
According to its Crunchbase profile, "Inari assembles profound changes in the industry for growers, consumers and the environment. It is a flagship company that launches an agricultural plant breeding technology company. It reintroduces nature’s genetic diversity and working to identify some of today’s major challenges, including climate change."
The four-year-old startup also raised a $40 million Series B round in 2018.
The round brings total funding raised by Cambridge companies in sustainability over the past month to $107 million. The local sustainability industry has produced 12 funding rounds over the past year, yielding a total of $516 million in venture funding.
In other local funding news, therapeutics company Oncorus announced a $79 million Series B funding round on Aug. 21, led by Cowen Healthcare Investments.
According to Crunchbase, "Oncorus, Inc. is a lean early-stage biotechnology company developing a next-generation immunotherapy platform to treat cancer. Oncorus was founded by MPM Managing Director Mitch Finer, a well-known biotechnology entrepreneur. Oncorus is a leader in corporate philanthropy, and has taken a pledge to donate a portion of product sales to fund promising cancer research and to support cancer care in the developing world."
Founded in 2015, the company has raised two previous rounds, including a $4.9 million Series A round in 2016.
Meanwhile, personal health and fertility company Legacy raised $150,000 in seed funding, announced on Aug. 19. The round was financed by Y Combinator.
From the company's Crunchbase profile, "Incubated at Harvard's Innovation Labs in 2018, Legacy won TechCrunch Disrupt before raising funds from Bain Capital Ventures. Male fertility has declined by 50%, and Legacy helps men test, improve, and freeze their sperm. This is important for all men to preserve their fertility, but especially to the 1/7 couples that face infertility — up to half of which is due to the man."
Legacy last raised $1.5 million in seed funding earlier this year.
This story was created automatically using local investment data, then reviewed by an editor. Click here for more about what we're doing. Got thoughts? Go here to share your feedback.
